10-144-283 Me. Code R. § 2

Current through 2024-49, December 4, 2024
Section 144-283-2 - DEFINITIONS
A. As used in this rule, unless the context indicates otherwise, the following terms have the following meanings:
1. Birthing center means any non-hospital health facility, institution, or place designed to accommodate mothers giving birth away from home at the culmination of normal, uncomplicated pregnancies.
2. Child Development Services (CDS) system means an Intermediate Educational Unit that provides both early intervention (birth through two years of age) and Free Appropriate Public Education (FAPE for ages three through five years of age) under the supervision of the Maine Department of Education.
3. Core condition means a disorder included in the Recommended Uniform Screening Panel (RUSP) for which Maine NBS specimens must be tested using established laboratory markers/analytes. See Appendix A.
4.Designated courier means a professional delivery service responsible for transporting newborn blood samples daily, Monday through Saturday, for a contracted laboratory.
5. Designated screening laboratory means the laboratory with which the Department contracts to analyze NBS specimens and report the NBS screening results to the Department.
6.Department means the Department of Health and Human Services Maine Center for Disease Control and Prevention.
7. Healthcare provider means a physician, advanced practice nurse, midwife or other licensed professional acting as primary healthcare provider for the infant.
8. Principal birthing attendant means any adult who acts as the primary attendant during a delivery that occurs at a site other than a hospital or birthing center.
9. Residual filter paper specimen means the portion of NBS specimen that remains after screening is complete.
10. Secondary condition means a disorder that can be detected in the differential diagnosis of a core condition. See Appendix A.
11. Time-critical condition means a disorder that may manifest with acute symptoms in the first days of life and require immediate treatment to reduce the risk of morbidity and mortality. See Appendix B.

10-144 C.M.R. ch. 283, § 2